+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dysmenorrhea - Epidemiology Forecast to 2030

  • ID: 5180471
  • Report
  • October 2020
  • Region: Global
  • 100 pages
  • DelveInsight
UP TO OFF
until Dec 31st 2020
1 of 2
This ‘Dysmenorrhea- Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Dysmenorrhea epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Dysmenorrhea Understanding

Painful menstrual periods in medical term are described as Dysmenorrhea, which is often called as “menstrual cramps” in simpler terms. Dysmenorrhea can be classified into two types: Primary Dysmenorrhea and Secondary Dysmenorrhea. Primary dysmenorrhea is common menstrual cramps related to the normal process of menstruation. These cramps are recurrent and are not due to other diseases. Pain can range from mild to severe, can typically last 12-72 hours, and can be accompanied by nausea and vomiting, fatigue, and even diarrhea. Whereas, in secondary dysmenorrhea the pain is caused by any disorder in the woman's reproductive organs. Pain usually begins earlier in the menstrual cycle and lasts longer than common menstrual cramps. Contrary to the primary dysmenorrhea, in this type pain is not typically accompanied by nausea, vomiting, fatigue, or diarrhea. The most common cause of secondary dysmenorrhea is endometriosis. The general cause behind menstrual cramps are the contractions (tightening) in the uterus by a chemical called prostaglandin. However, in secondary dysmenorrhea pain is caused by a disease in the woman's reproductive organs such as endometriosis, adenomyosis, pelvic inflammatory disease, cervical stenosis and fibroids.

Dysmenorrhea is common in women from every age and region; however, certain risk factors which add to the increased risk are smoking, consuming alcohol during their menstrual cycle, being overweight or obese, sexual abuse, Low body mass index, etc.

Epidemiology Perspective

The Dysmenorrhea epidemiology division provides insights about historical and current patient pool and forecasted trends for each seven major countries. The Dysmenorrhea epidemiology data are studied through Dysmenorrhea possible division to give a better understanding of the Disease scenario in the 7MM.

The disease epidemiology covered in the report provides historical as well as forecasted DYSMENORRHEA epidemiology [segmented as Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea), Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea, Severity-specific Prevalent Cases of Primary dysmenorrhea, Severity-specific Prevalent Cases of Secondary dysmenorrhea, Treated cases of Primary and Secondary Dysmenorrhea] scenario of Dysmenorrhea in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2030.

Dysmenorrhea Detailed Epidemiology Segmentation
  • In the year 2017, the total prevalent cases of Dysmenorrhea were 134,524,953 in the 7MM. The United States, in 2017, accounted for 58,670,651 cases (the highest number among the 7MM countries).
  • Among the EU-5 countries, the highest number of cases of Dysmenorrhea were in Germany, i.e. 13,122,996 cases in the year 2017, which is estimated to rise by the year 2030.
  • Spain accounted for the least number of prevalent cases, i.e., 445,364 cases in 2017.
  • Among the 7MM, Japan accounted for 18,442,399, and 2,410,771 Primary and Secondary Dysmenorrhea cases, respectively in 2017.
Scope of the Report
  • The Dysmenorrhea report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
  • The Dysmenorrhea Report and Model provide an overview of the risk factors and global trends of dysmenorrhea in the seven major markets (7MM: United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan).
  • The report provides insight about the historical and forecasted patient pool of Dysmenorrhea in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Dysmenorrhea.
  • The report provides the segmentation of the Dysmenorrhea epidemiology by Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the 7MM.
  • The report provides the segmentation of the Dysmenorrhea epidemiology by severity-specific prevalent cases of Primary and Secondary dysmenorrhea in the 7MM.
  • The report provides the segmentation of the Dysmenorrhea epidemiology by Treated Patient Pool of Primary and Secondary dysmenorrhea in the 7MM.
Report Highlights
  • 11-Year Forecast Of Dysmenorrhea Epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the 7MM
  • Total Diagnpsed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in The 7MM.
  • Severity-specific Prevalent Cases of Primary and Secondary dysmenorrhea in the 7MM.
  • Treated cases of Primary and Secondary dysmenorrhea in the 7MM.
KOL - Views

The researchers interview, KOL's and SME's opinion through primary research to fill the data gaps and validate the secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the over DYSMENORRHEA scenario of the indications.

Key Questions
  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Dysmenorrhea ?
  • What are the key findings pertaining to the Dysmenorrhea epidemiology across the 7MM and which country will have the highest number of patients during the study period (2017-2030)?
  • What would be the total number of patients of Dysmenorrhea across the 7MM during the study period (2017-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the study period (2017-2030)?
  • At what CAGR the patient population is expected to grow in the 7MM during the study period (2017-2030)?
  • What are the various recent and upcoming events which are expected to improve the diagnosis of Dysmenorrhea?
Reasons to Buy

The Dysmenorrhea Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Dysmenorrhea market
  • Quantify patient populations in the global Dysmenorrhea market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Dysmenorrhea therapeutics in each of the markets covered
  • Understand the magnitude of Dysmenorrhea population by its severity
  • The Dysmenorrhea epidemiology report and model were written and developed by Masters and PhD level epidemiologists
  • The Dysmenorrhea Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources
Key Assessments
  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population
Geography Covered:
  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan
Study Period: 2017-2030
Note: Product cover images may vary from those shown
2 of 2
1. Key Insights

2. Executive Summary of Dysmenorrhea

3. Epidemiology and Market Methodology

4. Dysmenorrhea: Disease Background and Overview
4.1. Types of Dysmenorrhea
4.2. Risk Factors
4.3. Signs and Symptoms
4.4. Pathophysiology
4.5. Diagnosis
4.6. Diagnostic Algorithm
4.7. Diagnostic Guidelines
4.7.1. National Institute for Health and Care Excellence (NICE) Guidelines

5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale
5.3. Epidemiology Scenario: 7MM
5.3.1. Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the 7MM
5.3.2. Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the 7MM
5.3.3. Severity-specific Prevalent Cases of Dysmenorrhea in the 7MM
5.3.4. Treated cases of Primary and Secondary Dysmenorrhea in the 7MM
5.4. The United States Epidemiology
5.4.1. Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United States
5.4.2. Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United States
5.4.3. Severity-specific Prevalent Cases of Dysmenorrhea in the United States
5.4.4. Treated cases of Primary and Secondary Dysmenorrhea in the United States
5.5. EU-5 Epidemiology
5.6. Germany
5.6.1. Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Germany
5.6.2. Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Germany
5.6.3. Severity-specific Prevalent Cases of Dysmenorrhea in Germany
5.6.4. Treated cases of Primary and Secondary Dysmenorrhea in Germany
5.7. France
5.7.1. Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in France…
5.7.2. Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in France
5.7.3. Severity-specific Prevalent Cases of Dysmenorrhea in France
5.7.4. Treated cases of Primary and Secondary Dysmenorrhea in France
5.8. Italy
5.8.1. Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Italy
5.8.2. Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Italy
5.8.3. Severity-specific Prevalent Cases of Dysmenorrhea in Italy
5.8.4. Treated cases of Primary and Secondary Dysmenorrhea in Italy
5.9. Spain
5.9.1. Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Spain
5.9.2. Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Spain
5.9.3. Severity-specific Prevalent Cases of Dysmenorrhea in Spain
5.9.4. Treated cases of Primary and Secondary Dysmenorrhea in Spain
5.10. The United Kingdom
5.10.1. Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United Kingdom
5.10.2. Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United Kingdom
5.10.3. Severity-specific Prevalent Cases of Dysmenorrhea in the United Kingdom
5.10.4. Treated cases of Primary and Secondary Dysmenorrhea in the United Kingdom
5.11. Japan Epidemiology
5.11.1. Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Japan
5.11.2. Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Japan
5.11.3. Severity-specific Prevalent Cases of Dysmenorrhea in Japan
5.11.4. Treated cases of Primary and Secondary Dysmenorrhea in Japan

6. Appendix
6.1. Bibliography
6.2. Report Methodology
6.3. Publisher Capabilities

7. Disclaimer

8. About the Publisher

List of Tables
Table 1 Summary of Dysmenorrhea, Epidemiology, and Key Events (2017-2030)
Table 2 Stages of Endometriosis
Table 3 Differential Diagnosis of Dysmenorrhea
Table 4 NICE Recommendations
Table 5 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the 7MM (2017-2030)
Table 6 Total Prevalent Cases of Primary and Secondary Dysmenorrhea in the 7MM (2017-2030)
Table 7 Total Diagnosed cases of Dysmenorrhea, and its types (Primary dysmenorrhea, and Secondary dysmenorrhea) in the 7MM (2017-2030)
Table 8 Severity-specific Prevalent Cases of Primary dysmenorrhea in the 7MM (2017-2030)
Table 9 Severity-specific Prevalent Cases of Secondary dysmenorrhea in the 7MM (2017-2030)
Table 10 Total Treated cases of Primary and Secondary Dysmenorrhea in the 7MM (2017-2030)
Table 11 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United States (2017-2030)
Table 12 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United States (2017-2030)
Table 13 Severity-specific Prevalent Cases of Primary dysmenorrhea in the United States (2017-2030)
Table 14 Severity-specific Prevalent Cases of Secondary dysmenorrhea in the United States (2017-2030)
Table 15 Total Treated cases of Primary and Secondary Dysmenorrhea in the United States (2017-2030)
Table 16 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Germany (2017-2030)
Table 17 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Germany (2017-2030)
Table 18 Severity-specific Prevalent Cases of Primary dysmenorrhea in Germany (2017-2030)
Table 19 Severity-specific Prevalent Cases of Secondary dysmenorrhea in Germany (2017-2030)
Table 20 Total Treated cases of Primary and Secondary Dysmenorrhea in Germany (2017-2030)
Table 21 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in France (2017-2030)
Table 22 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in France (2017-2030)
Table 23 Severity-specific Prevalent Cases of Primary dysmenorrhea in France (2017-2030)
Table 24 Severity-specific Prevalent Cases of Secondary dysmenorrhea in France (2017-2030)
Table 25 Total Treated cases of Primary and Secondary Dysmenorrhea in France (2017-2030)
Table 26 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Italy (2017-2030)
Table 27 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Italy (2017-2030)
Table 28 Severity-specific Prevalent Cases of Primary dysmenorrhea in Italy (2017-2030)
Table 29 Severity-specific Prevalent Cases of Secondary dysmenorrhea in Italy (2017-2030)
Table 30 Total Treated cases of Primary and Secondary Dysmenorrhea in Italy (2017-2030)
Table 31 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Spain (2017-2030)
Table 32 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Spain (2017-2030)
Table 33 Severity-specific Prevalent Cases of Primary dysmenorrhea in Spain (2017-2030)
Table 34 Severity-specific Prevalent Cases of Secondary dysmenorrhea in Spain (2017-2030)
Table 35 Total Treated cases of Primary and Secondary Dysmenorrhea in Spain (2017-2030)
Table 36 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United Kingdom (2017-2030)
Table 37 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United Kingdom (2017-2030)
Table 38 Severity-specific Prevalent Cases of Primary dysmenorrhea in the United Kingdom (2017-2030)
Table 39 Severity-specific Prevalent Cases of Secondary dysmenorrhea in the United Kingdom (2017-2030)
Table 40 Total Treated cases of Primary and Secondary Dysmenorrhea in the United Kingdom (2017-2030)
Table 41 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Japan (2017-2030)
Table 42 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Japan (2017-2030)
Table 43 Severity-specific Prevalent Cases of Primary dysmenorrhea in Japan (2017-2030)
Table 44 Severity-specific Prevalent Cases of Secondary dysmenorrhea in Japan (2017-2030)
Table 45 Total Treated cases of Primary and Secondary Dysmenorrhea in Japan (2017-2030)

List of Figures
Figure 1 Dysmenorrhea SWOT Analysis
Figure 3 Types of Dysmenorrhea
Figure 4 Endometriosis
Figure 5 Uterine fibroids
Figure 6 Adenomyosis
Figure 7 Risk Factors
Figure 8 Symptoms
Figure 9 Pathophysiology of Adolescent dysmenorrhea
Figure 10 Laparoscopy
Figure 11 Hysteroscopy
Figure 12 Diagnostic Algorithm
Figure 13 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the 7MM (2017-2030)
Figure 14 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the 7MM (2017-2030)
Figure 15 Severity-specific Prevalent Cases of Primary dysmenorrhea in the 7MM (2017-2030)
Figure 16 Severity-specific Prevalent Cases of Secondary dysmenorrhea in the 7MM (2017-2030)
Figure 17 Total Treated cases of Primary and Secondary Dysmenorrhea in the 7MM (2017-2030)
Figure 18 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United States (2017-2030)
Figure 19 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United States (2017-2030)
Figure 20 Severity-specific Prevalent Cases of Primary dysmenorrhea in the United States (2017-2030)
Figure 21 Severity-specific Prevalent Cases of Secondary dysmenorrhea in the United States (2017-2030)
Figure 22 Treated cases of Primary and Secondary Dysmenorrhea in the United States (2017-2030)
Figure 23 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Germany (2017-2030)
Figure 24 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Germany (2017-2030)
Figure 25 Severity-specific Prevalent Cases of Primary dysmenorrhea in Germany (2017-2030)
Figure 26 Severity-specific Prevalent Cases of Secondary dysmenorrhea in Germany (2017-2030)
Figure 27 Treated cases of Primary and Secondary Dysmenorrhea in Germany (2017-2030)
Figure 28 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in France (2017-2030)
Figure 29 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in France (2017-2030)
Figure 30 Severity-specific Prevalent Cases of Primary dysmenorrhea in France (2017-2030)
Figure 31 Severity-specific Prevalent Cases of Secondary dysmenorrhea in France (2017-2030)
Figure 32 Treated cases of Primary and Secondary Dysmenorrhea in France (2017-2030)
Figure 33 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Italy (2017-2030)
Figure 34 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Italy (2017-2030)
Figure 35 Severity-specific Prevalent Cases of Primary dysmenorrhea in Italy (2017-2030)
Figure 36 Severity-specific Prevalent Cases of Secondary dysmenorrhea in Italy (2017-2030)
Figure 37 Treated cases of Primary and Secondary Dysmenorrhea in Italy (2017-2030)
Figure 38 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Spain (2017-2030)
Figure 39 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Spain (2017-2030)
Figure 40 Severity-specific Prevalent Cases of Primary dysmenorrhea in Spain (2017-2030)
Figure 41 Severity-specific Prevalent Cases of Secondary dysmenorrhea in Spain (2017-2030)
Figure 42 Treated cases of Primary and Secondary Dysmenorrhea in Spain (2017-2030)
Figure 43 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United Kingdom (2017-2030)
Figure 44 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in the United Kingdom (2017-2030)
Figure 45 Severity-specific Prevalent Cases of Primary dysmenorrhea in the United Kingdom (2017-2030)
Figure 46 Severity-specific Prevalent Cases of Secondary dysmenorrhea in the United Kingdom (2017-2030)
Figure 47 Treated cases of Primary and Secondary Dysmenorrhea in the United Kingdom (2017-2030)
Figure 48 Total Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Japan (2017-2030)
Figure 49 Total Diagnosed Prevalent Cases of Dysmenorrhea and its Types (Primary and Secondary Dysmenorrhea) in Japan (2017-2030)
Figure 50 Severity-specific Prevalent Cases of Primary dysmenorrhea in Japan (2017-2030)
Figure 51 Severity-specific Prevalent Cases of Secondary dysmenorrhea in Japan (2017-2030)
Figure 52 Treated cases of Primary and Secondary Dysmenorrhea in Japan (2017-2030)
Note: Product cover images may vary from those shown
Adroll
adroll